Article

Embracing the future of work to unlock R&D productivity

Measuring the return from pharmaceutical innovation 2018

The biopharma industry continues to face challenges this year, with projected returns on investment in R&D at the lowest levels since our analysis began in 2010. Can this trend be reversed?